title: UV-B-induced damage to the lens in vitro: prevention by caffeine.
abstract: Ultraviolet (UV) irradiation is one of the significant risk factors in the genesis of cataracts. Pathogenetically, the process can be triggered by the intraocular generation of various reactive species of oxygen that are well known to be initiated by the penetration of light, especially of the UV frequencies. The contribution of UV exposure in the etiology of this disease is likely to increase further due to ozone depletion in the upper atmosphere. The present studies were undertaken to examine if the UV effects can be attenuated with the xanthine-based alkaloids primarily present in tea and coffee. We have examined this possibility by in vitro lens culture studies with caffeine. As expected, mice lenses incubated in Tyrode solution exposed to UV at 302 nm are physiologically damaged, as evidenced by the inhibition of the active transport of (86)Rb(+), an ion acting as a surrogate of the K(+). There was a simultaneous decrease in the levels of adenosine triphosphate and glutathione. The addition of caffeine to the medium prevented such deleterious effects. That caffeine and perhaps other xanthinoids have a protective effect against cataract formation induced by UV has hence been demonstrated for the first time.
authors.affiliation: Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD 21201, USA. svarm001@umaryland.edu
authors.forename: Shambhu D
authors.initials: SD
authors.lastname: Varma
authors.forename: Kavita R
authors.initials: KR
authors.lastname: Hegde
authors.forename: Svitlana
authors.initials: S
authors.lastname: Kovtun
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001693:Biological Transport, Active; D002110:Caffeine / Q000627:therapeutic use*; D002386:Cataract / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D005978:Glutathione / Q000378:metabolism; D066298:In Vitro Techniques; D007908:Lens, Crystalline / Q000187:drug effects / Q000378:metabolism / Q000528:radiation effects*; D051379:Mice; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D011833:Radiation Injuries, Experimental / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control; D017382:Reactive Oxygen Species / Q000378:metabolism; D012414:Rubidium Radioisotopes; D014466:Ultraviolet Rays / Q000009:adverse effects*
chemical_list: D010726:Phosphodiesterase Inhibitors; D017382:Reactive Oxygen Species; D012414:Rubidium Radioisotopes; D002110:Caffeine; D000255:Adenosine Triphosphate; D005978:Glutathione
references.citation: Invest Ophthalmol. 1970 Aug;9(8):629-38
references.pmid: 5456505
references.citation: Ophthalmic Res. 2004 Sep-Oct;36(5):264-9
references.pmid: 15583432
references.citation: Curr Eye Res. 1995 Aug;14(8):643-9
references.pmid: 8529399
references.citation: Methods Biochem Anal. 1954;1:341-56
references.pmid: 13193535
references.citation: Ophthalmology. 2008 Apr;115(4):597-8
references.pmid: 18387405
references.citation: Br J Ophthalmol. 1982 Jan;66(1):35-42
references.pmid: 7055541
references.citation: Am J Ophthalmol. 2001 Jul;132(1):19-26
references.pmid: 11438049
references.citation: J Ocul Pharmacol Ther. 2007 Oct;23(5):492-502
references.pmid: 17900232
references.citation: N Engl J Med. 1988 Dec 1;319(22):1429-33
references.pmid: 3185661
references.citation: Food Chem Toxicol. 1991 Jan;29(1):1-6
references.pmid: 1847890
references.citation: Ophthalmic Res. 2002 Jul-Aug;34(4):258-63
references.pmid: 12297700
references.citation: Arch Biochem Biophys. 1959 May;82(1):70-7
references.pmid: 13650640
references.citation: Curr Eye Res. 1984 Jan;3(1):59-65
references.pmid: 6690229
references.citation: Mol Cell Biochem. 2004 Nov;266(1-2):37-56
references.pmid: 15646026
references.citation: JAMA. 1998 Aug 26;280(8):714-8
references.pmid: 9728643
references.citation: Ophthalmology. 2008 Apr;115(4):599-607.e1
references.pmid: 18387406
references.citation: Biochim Biophys Acta. 2003 Jun 11;1621(3):246-52
references.pmid: 12787921
references.citation: Curr Eye Res. 1984 Jan;3(1):35-57
references.pmid: 6360540
references.citation: Curr Eye Res. 1984 Jan;3(1):145-50
references.pmid: 6690217
references.citation: Exp Eye Res. 1990 Jun;50(6):805-12
references.pmid: 2373172